Progressive supranuclear palsy is a rare condition that affects the brain. The condition is also called Steele-Richardson-Olszewski syndrome. Progressive supranuclear palsy causes the brain cells that ...

Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are sporadic four-repeat tauopathies that have characteristic clinical and neuropathologic profiles, but also share overlapping ...

The clinical diagnosis of progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) remains challenging due to heterogeneity of the diseases. The final antemortem diagnosis was incorrect ...

In Alzheimer's disease, aggregation of Aβ precedes tau aggregation, but in primary tauopathies, the upstream instigators are shrouded in mystery. A study published May 25 in Science Advances casts ...

Researchers from the University of Melbourne have established how two diseases that present in similar ways are in fact quite different. Progressive Supranuclear palsy (PSP) and Parkinson's Disease ...

Background Progressive supranuclear palsy and Parkinson's disease have characteristic clinical and neuropathologic profiles, but also share overlapping clinical features. This study aimed to analyze ...

BARCELONA, Spain, October 21, 2025--(BUSINESS WIRE)--Spanish international pharmaceutical company Ferrer has announced the completion of patient recruitment for the PROSPER study, a Phase II clinical ...

CurePSP announced the latest recipients of the Collaborative Approaches to Resources, Education and Support (CARES) grants, awarding a total of $155,000 to four projects spanning seven leading medical ...

Progressive supranuclear palsy (PSP) is a rare brain disorder that affects approximately 6 in 100,000 people worldwide. It causes muscle weakness and affects gait, balance and overall movement, as ...

Progressive supranuclear palsy (PSP) is a rare brain disorder that affects approximately 6 in 100,000 people worldwide. It causes muscle weakness and affects gait, balance and overall movement, as ...